CARFILZOMIB IN RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM): FRAILTY SUBGROUP ANALYSIS FROM PHASE 3 ASPIRE AND ENDEAVOR
Facon, T., Niesvizky, R., Weisel, K., Bringhen, S., Ho, P. J., Obreja, M., Yang, Z., Klippel, Z., Blaedel, J., Mezzi, K., Siegel, D.Volume:
3
Journal:
HemaSphere
DOI:
10.1097/01.hs9.0000563824.64379.80
Date:
June, 2019
File:
PDF, 608 KB
2019